SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 3, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 2 insiders, $1.4M total
Actionable Insight • Neutral

Insider sales are routine option-exercise tax-withholding transactions. Do not read bearish signal. Monitor upcoming quarterly earnings (likely August 2026) for pipeline progress on Tyvaso and any clinical data readouts, those are the material catalysts for UTHR, not this cluster.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$547.22
T+0 close · Jun 3, 2026 · via day close
Latest settled
−6.15%
T+60 · $513.54
Vs SPY
−7.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 4 $547.22entry
  2. T+1 · 6mo ago −0.16%α +2.44% · $546.37
  3. T+5 · 5mo ago −0.33%α +2.22% · $545.40
  4. T+20 · 4mo ago +1.59%α +3.21% · $555.91
  5. T+60 · 3mo ago −6.15%α −7.77% · $513.54

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt and CFO James Edgemond sold a combined ~$1.41M in UTHR shares over five trading days, entirely from exercised options. These are routine same-day stock-for-tax sales (cashless exercises), not open-market liquidation of unrestricted shares. At 0.006% of UTHR's $22.9B market cap, the dollar value is trivial and carries no informational signal. The cross-filing actuarial verdicts show near-uniform amplification for this combo type, but the standalone economics of these sales are too small to warrant an impact override.

Key Financial Metrics

Direction
selling
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 2,820 shares total at ~$535-562 over 3 trading days, all from option exercises at exercises at $0 and $146.03 per share.
  • CFO James Edgemond sold 3,200 shares total at ~$545-561 over 2 trading days, all from option exercises at exercises at $0 and $117.76 per share.
  • Total open-market sale proceeds: ~$2.5M (includes proceeds from shares sold same-day as option exercise). Net cash received by insiders after strike costs: ~$1.41M.
  • All sales are same-day sale-to-cover transactions from option exercise, routine tax-withholding pattern, not discretionary portfolio liquidation.
  • Total sale value is 0.006% of UTHR's $22.9B market cap, economically trivial.

Financial Impact

Total open-market sales proceeds of ~$1.41M (net of strike costs), 0.006% of market cap. Trivial.

Risk Factors

  • CEO Rothblatt sold shares at an average of ~$545, near 52-week highs, but the pattern is consistent with her regular option-exercise cadence.
  • No open-market purchases alongside these sales to offset selling signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1780518915452

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026